Literature DB >> 22910475

Psychiatric comorbidity in cocaine users treated in therapeutic community: substance-induced versus independent disorders.

Esperanza Vergara-Moragues1, Francisco González-Saiz, Oscar M Lozano, Patricia Betanzos Espinosa, Fermín Fernández Calderón, Izaskun Bilbao-Acebos, Miguel Pérez García, Antonio Verdejo García.   

Abstract

This is a cross-sectional study of 227 cocaine dependent individuals in six different therapeutic communities (TCs) within a single treatment network in Andalusia (Spain). The primary aim of the study is to examine the prevalence of lifetime psychiatric comorbidity in this sample using the Psychiatric Research Interview for Substance and Mental Disorders (PRISM). Diagnoses were assessed 15-20 days after admission. The data indicate that more than 65% of the sample experienced a lifetime co-occurring psychiatric comorbidity. Substance-induced mood (21.6%) and psychotic (11.5%) disorders were more prevalent in this population than independent mood (12.3%) and psychotic (7.5%) disorders. These data suggest the need to introduce changes in these centers, both in the diagnostic aspects and in the treatment programs.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22910475     DOI: 10.1016/j.psychres.2012.07.043

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  15 in total

1.  A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence.

Authors:  Peter D Alexander; Kristina M Gicas; Taylor S Willi; Clara N Kim; Veronika Boyeva; Ric M Procyshyn; Geoff N Smith; Allen E Thornton; William J Panenka; Andrea A Jones; Fidel Vila-Rodriguez; Donna J Lang; G William MacEwan; William G Honer; Alasdair M Barr
Journal:  Psychopharmacology (Berl)       Date:  2017-02-11       Impact factor: 4.530

2.  Gambling Problems Among Community Cocaine Users.

Authors:  Magali Dufour; Noël Nguyen; Karine Bertrand; Michel Perreault; Didier Jutras-Aswad; Adèle Morvannou; Julie Bruneau; Djamal Berbiche; Élise Roy
Journal:  J Gambl Stud       Date:  2016-09

3.  Demographic and clinical characteristics of current comorbid psychiatric disorders in a randomized clinical trial for adults with stimulant use disorders.

Authors:  Diane Warden; Katherine Sanchez; Tracy Greer; Thomas Carmody; Robrina Walker; Adriane Dela Cruz; Marisa Toups; Chad Rethorst; Madhukar H Trivedi
Journal:  Psychiatry Res       Date:  2016-09-15       Impact factor: 3.222

4.  Markers for Severity of Problems in Interpersonal Relationships of Crack Cocaine Users from a Brazilian Multicenter Study.

Authors:  Mayra Pacheco Pachado; Juliana Nichterwitz Scherer; Luciano Santos Pinto Guimarães; Lisia von Diemen; Flavio Pechansky; Felix Henrique Paim Kessler; Rosa Maria Martins de Almeida
Journal:  Psychiatr Q       Date:  2018-12

Review 5.  Cognitive Function as a Transdiagnostic Treatment Target in Stimulant Use Disorders.

Authors:  Mehmet Sofuoglu; Elise E DeVito; Andrew J Waters; Kathleen M Carroll
Journal:  J Dual Diagn       Date:  2016

6.  Neuroticism associated with cocaine-induced psychosis in cocaine-dependent patients: a cross-sectional observational study.

Authors:  Carlos Roncero; Constanza Daigre; Carmen Barral; Elena Ros-Cucurull; Lara Grau-López; Laia Rodríguez-Cintas; Nuria Tarifa; Miguel Casas; Sergi Valero
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

7.  A Biomarker to Differentiate between Primary and Cocaine-Induced Major Depression in Cocaine Use Disorder: The Role of Platelet IRAS/Nischarin (I1-Imidazoline Receptor).

Authors:  Benjamin Keller; Joan-Ignasi Mestre-Pinto; María Álvaro-Bartolomé; Diana Martinez-Sanvisens; Magí Farre; M Julia García-Fuster; Jesús A García-Sevilla; Marta Torrens
Journal:  Front Psychiatry       Date:  2017-12-01       Impact factor: 4.157

8.  Evaluation of plasma cytokines in patients with cocaine use disorders in abstinence identifies transforming growth factor alpha (TGFα) as a potential biomarker of consumption and dual diagnosis.

Authors:  Rosa Maza-Quiroga; Nuria García-Marchena; Pablo Romero-Sanchiz; Pedro Araos; Vicente Barrios; María Pedraz; Antonia Serrano; Raquel Nogueira-Arjona; Juan Jesus Ruiz; Maribel Soria; Rafael Campos; Julie Ann Chowen; Jesus Argente; Marta Torrens; Meritxell López-Gallardo; Eva María Marco; Fernando Rodríguez de Fonseca; Francisco Javier Pavón
Journal:  PeerJ       Date:  2017-10-12       Impact factor: 2.984

9.  Sex differences in psychiatric comorbidity and plasma biomarkers for cocaine addiction in abstinent cocaine-addicted subjects in outpatient settings.

Authors:  María Pedraz; Pedro Araos; Nuria García-Marchena; Antonia Serrano; Pablo Romero-Sanchiz; Juan Suárez; Estela Castilla-Ortega; Fermín Mayoral-Cleries; Juan Jesús Ruiz; Antoni Pastor; Vicente Barrios; Julie A Chowen; Jesús Argente; Marta Torrens; Rafael de la Torre; Fernando Rodríguez De Fonseca; Francisco Javier Pavón
Journal:  Front Psychiatry       Date:  2015-02-16       Impact factor: 4.157

10.  Psychopathology in Substance Use Disorder Patients with and without Substance-Induced Psychosis.

Authors:  Simon Zhornitsky; Andràs Tikàsz; Élie Rizkallah; Jean-Pierre Chiasson; Stéphane Potvin
Journal:  J Addict       Date:  2015-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.